Which approach would most strongly support enterohepatic cycling when interpreting PK data?

• A. A second peak after the initial decline.
• B. Evaluate bile flow modulators to observe attenuation of secondary peaks.
• C. If there are no secondary peaks, there is no enterohepatic cycling.
• D. Only Cmax matters for detection.

Answer: (B)

Enterohepatic cycling shows up in the concentration–time profile as a secondary rise or prolonged elimination due to drug being excreted into bile, passed into the gut, and reabsorbed. The strongest way to confirm this mechanism is to modulate the biliary pathway and see if the secondary feature changes. If you reduce or alter bile flow and the secondary peak or tailing diminishes or disappears, that directly ties the observed pattern to biliary excretion and reabsorption, providing strong causal evidence for enterohepatic cycling.

A simple observation of a second peak can be suggestive but not definitive because other factors—like delayed absorption, multi-compartment kinetics, or formulation effects—could mimic it. Conversely, the absence of a secondary peak doesn’t completely rule out enterohepatic cycling, since the phenomenon may be subtle or masked by other PK factors. Focusing only on the maximum concentration misses the value of the time-course information that reveals recycling, which is central to identifying enterohepatic cycling.